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Mast cells are critical promoters of adaptive immunity
in the contact hypersensitivity model, but themecha-
nism of allergen sensitization is poorly understood.
Using Mcpt5-CreTNFFL/FL mice, we show here that
the absence of TNF exclusively inmast cells impaired
the expansion of CD8+ T cells upon sensitization
and the T-cell-driven adaptive immune response to
elicitation. T cells primed in the absence of mast cell
TNF exhibited a diminished efficiency to transfer
sensitization to naive recipients. Specifically, mast
cell TNF promotes CD8+ dendritic cell (DC) matura-
tion and migration to draining lymph nodes. The
peripherally released mast cell TNF further critically
boosts the CD8+ T-cell-priming efficiency of CD8+
DCs, thereby linking mast cell effects on T cells to
DC modulation. Collectively, our findings identify
the distinct potential of mast cell TNF to amplify
CD8+ DC functionality and CD8+ T-cell-dominated
adaptive immunity,whichmaybeof great importance
for immunotherapy and vaccination approaches.
INTRODUCTION
Mast cells (MCs) are well established as key mediators in IgE-
triggered allergic reactions culminating at worst in the life-threat-
eninganaphylaxis.However, there is growingevidence for impor-
tant MC functions in innate and adaptive immune responses
(Abraham and St John, 2010). We and others demonstrated
MCs to impact on neutrophil recruitment to sites of inflammation
(Dudeck et al., 2011a; De Filippo et al., 2013; Weber et al., 2015;
Biedermann et al., 2000; Wezel et al., 2015; Wershil et al., 1991;
Zhang et al., 1992). In addition to local responses, MCs have
been shown to promote the induction of adaptive T cell re-
sponses (Dudeck et al., 2011a; Schubert et al., 2015; Heib
et al., 2007; Gregory et al., 2005; McLachlan et al., 2003). The
relevanceofMCs in Tcell expansion hasoftenbeen linked to their
regulation of dendritic cell (DC) migration from site of infection or
inflammation to draining lymph nodes (LNs) to present peripher-Cally engulfed antigens and prime antigen-specific T cells. Partic-
ularly, MCs have been shown to promote the migration of
epidermal Langerhans cells following IgE-mediated MC activa-
tion (Bryce et al., 2004; Jawdat et al., 2004) or in response to bac-
terial products (Heib et al., 2007; Shelburne et al., 2009; Jawdat
et al., 2006). Shelburne et al. (2009) defined a critical relevance
of MCs for recruitment of additional DCs to sites of bacterial
infection. Moreover, MCs have been reported to mediate the
accumulation of graft-derived tolerogenic DCs in draining LNs
via tumor necrosis factor (TNF) and GM-CSF release (de Vries
et al., 2011). Beside their effect on DC migration, MCs have
been reported to enhance DC maturation in vitro (Dudeck et al.,
2011b; Caron et al., 2001), antigen uptake, and cross-presenta-
tion (Amaral et al., 2007). In a recent report, we identified MCs
to be prerequisite for efficient DC migration to skin-draining
LNs and adaptive immune response upon contact hypersensitiv-
ity (CHS) (Dudeck et al., 2011a), but the underlying molecular
mechanism remains open. CHS is a chemical-induced T-cell-
dominated delayed-type hypersensitivity reaction reflecting the
human disease allergic contact dermatitis. Upon the first hapten
encounter, referred to as sensitization, skin-resident DCs engulf
hapten-modified self-proteins and migrate to skin-draining LNs
to prime hapten-specific T cells. Every following hapten chal-
lenge causes the recruitment of effector T cells, consequently
provoking a hapten-specific adaptive skin inflammation (Kaplan
et al., 2012; Martin, 2012, 2015). Because MCs are an important
source of the pro-inflammatory TNF, we herein addressed the
impact of MC-derived TNF on hapten-specific adaptive inflam-
mationusing theMcpt5-CreTNFFL/FLmouse line.Wehere identify
a critical role for MC-derived TNF in CD8+ DCmaturation, migra-
tion, and T-cell-priming efficiency and consequently in efficient
hapten-specific skin inflammation. Our findings highlight the po-
tential of MC-derived TNF to stimulate T-cell-driven adaptive im-
mune responses, which is highly relevant for immunotherapy or
vaccination strategies.RESULTS
Mast-Cell-Specific TNF Gene Inactivation
In order to evaluate the distinct impact of MC-derived TNF on
adaptive T-cell-driven immune responses, we generated miceell Reports 13, 399–411, October 13, 2015 ª2015 The Authors 399
with a selective inactivation of the TNF gene in connective-tis-
sue-type MCs by crossing the Mcpt5-Cre line (Scholten et al.,
2008) to TNFFL/FLmice (Grivennikov et al., 2005). Highly efficient
and MC-specific inactivation of the TNF gene in Mcpt5-
Cre+TNFFL/FL MCs was demonstrated by single-target amplifi-
cation of the TNF locus of single FACS-sorted peritoneal MCs
or non-MCs (see scheme in Figure S1). The fragment amplified
from Mcpt5-Cre+TNFFL/FL connective-tissue-type peritoneal
MCs always represented the deleted but never the loxP-flanked
situation, whereas the opposite result was obtained from non-
MCs (B cells and macrophages) and from all Cre control cells
(Figure 1; Table S1). Moreover, the selective and efficient TNF
knockout in MCs was confirmed at protein level. Virtually no
TNF was detected in supernatants of IgE plus antigen-stimu-
lated, in-vitro-expanded, peritoneal-cultured MCs (PCMCs)
from Mcpt5-Cre+TNFFL/FL mice, whereas stimulated PCMCs
from Cremice as well as lipopolysaccharide (LPS)-stimulated,
bone-marrow-derived DCs from both Mcpt5-Cre+TNFFL/FL
mice and Cre controls release high TNF levels (Figure 1B).
We further confirmed by means of flow cytometry analysis
that the MC number in the peritoneum and in ear skin was not
affected by the absence of TNF as compared to Cre litter-
mates (Figure 1C).
In order to exclude an effect of TNF absence on the degranu-
lation capacity of MCs in vivo, ear skin of Mcpt5-Cre+ TNFFL/FL
mice and Cre littermates was sensitized by the hapten 2,4-dini-
trofluorebenzene (DNFB) and MC degranulation was assessed
4 hr after application by Giemsa staining of ear skin sections
as described in the Experimental Procedures section. We found
that the degranulation of skin MCs in response to DNFB was not
altered inMcpt5-Cre+ TNFFL/FLmice lacking MC-derived TNF as
compared to Cre control mice when classified as extensive or
moderate degranulation (Figures 2A and 2B). Moreover, we
quantified the degranulation of in-vitro-expanded, PCMCs by
means of beta-hexosaminidase release as well as the secretion
of histamine and leukotriene C4 upon calcium ionophore stimu-
lation. As demonstrated in Figure 2, we could not detect any
differences in release capacities in absence or presence of
MC-TNF (Figures 2C–2E). Consequently, Mcpt5-Cre+ TNFFL/FL
mice represent a model of highly efficient and specific TNF inac-
tivation exclusively in connective-tissue-type MCs without alter-
ations of MC numbers and MC degranulation capacity.
MC-Derived TNF Is Required for Hapten-Induced
Adaptive Immunity
We previously demonstrated a critical relevance for MCs in
adaptive immune responses to contact allergens (Dudeck
et al., 2011a). To address the underlying mechanism, we herein
analyzed the impact of MC-derived TNF on the hapten-specific
adaptive inflammation. Mcpt5-Cre+TNFFL/FL mice and Cre lit-
termates were epicutaneously sensitized with DNFB and chal-
lenged 6 days later on the ear. The hapten-specific adaptive
skin inflammation was quantified as ear swelling 24 hr post-
challenge. Mcpt5-Cre+TNFFL/FL mice exhibited a significantly
reduced ear swelling response compared to Cre controls (Fig-
ure 3A) accompanied by a dramatic reduction of neutrophils and
CD8+ T cells infiltrating the inflamed skin (Figure 3B). Conse-
quently, MC-TNF proved to be critical for efficient hapten-spe-400 Cell Reports 13, 399–411, October 13, 2015 ª2015 The Authorscific adaptive skin inflammation including tissue edema and
CD8+ T cell and neutrophil recruitment.
This impact may arise from locally restricted MC functions
as gatekeepers of cell infiltration but also from a relevance of
MC-derived TNF in priming the adaptive response. We therefore
analyzed the ear swelling response in naiveMcpt5-Cre+TNFFL/FL
and Cre recipients adoptively transferred with LN cells from
sensitized WT donor mice. T cells were isolated from inguinal
LNs of sensitized WT mice at day 6 post-sensitization. Equal
numbers of T cells were adoptively transferred to Mcpt5-
Cre+TNFFL/FL and Cre controls, recipients were challenged
24 hr post transfer, and ear swelling was determined further
24 hr later. We found that the absence ofMC-derived TNF during
challenge, but not in the sensitization phase, already reduced the
T-cell-driven skin inflammation (Figure 3C).
In order to distinguish MC-TNF effects on hapten sensitization
from those on skin inflammation during challenge, we analyzed
the LN hypertrophy in inguinal LNs 72 hr post-sensitization.
We found a slight but significant reduction of CD4+ T cells
and respective CD25+Foxp3 effector T cells in Mcpt5-Cre+
TNFFL/FL mice as compared to Cre controls. Importantly, the
expansion of CD8+ T cells and CD8+CD25+ T cells was markedly
diminished in absence of MC-derived TNF (Figure 3D). We
further questioned whether the resulting effector T cells may
exhibit inadequacies in driving efficient adaptive CHS response.
To this end, we performed trans-sensitization experiments in
which inguinal LNs were isolated from Mcpt5-Cre+TNFFL/FL or
Cre mice 72 hr post-sensitization and equal amounts of pan
T cells were adoptively transferred into naive WT recipients. Re-
cipients were challenged 24 hr after transfer, and ear swelling
was measured at 24 hr post-challenge. Surprisingly, we de-
tected a significantly reduced ear swelling in WT mice that
received T cells from Mcpt5-Cre+TNFFL/FL donors compared to
WT recipients transferred with T cells from Cre donors (Fig-
ure 4A). In addition, CD8+ T cell numbers were significantly
reduced in the challenged ear skin of WT recipient mice trans-
ferred with T cells from Mcpt5-Cre+TNFFL/FL donor mice at
24 hr post-challenge, whereas the CD4+ T cell population was
not affected (Figure 4B). The reduced numbers of CD8+ T cells
came along with a dramatic reduction of neutrophil infiltration
almost to the level of DNFB-treated controls that received
T cells from vehicle-treated donor mice (Figure 4B). Recipient
mice that received T cells from Mcpt5-Cre+TNFFL/FL donor
mice further showed an increase in the fraction of resting macro-
phages, whereas the level of inflammatory macrophages was
not altered. These unexpected data indicate that T cells primed
in the absence of MC-TNF exhibit a reduced capacity to elicit
efficient hapten-specific adaptive immune responses.
MC-Derived TNF Promotes CD8+ DC Migration and
Maturation
DC migration from inflamed skin to skin-draining LNs to prime
hapten-specific effector T cells is prerequisite for sensitization
of naive mice (Kaplan et al., 2012; Martin, 2012, 2015). We
therefore analyzed the DC migration and maturation in Mcpt5-
Cre+TNFFL/FL mice compared to Cre controls. The epicutane-
ous application of the hapten fluorescein isothiocyanate (FITC)
allows for the quantification of FITC-bearing DCs migrated
Figure 1. Efficient Inactivation of the TNF Gene
in Connective-Tissue-type MCs
(A) Results of the single target amplification of the
loxP-flanked TNF locus from FACS-sorted single MCs
and non-MCs from the peritoneal cavity. The PCR
tubes containing single MCs and non-MCs (macro-
phages and B cells) from peritoneal cavity (PC) of
Mcpt5-Cre+ TNF Fl/Fl and Cre mice as well as nega-
tive control tubes were subjected to two rounds of
amplification as described in the Experimental Pro-
cedures section. The graphs display the fraction
deleted (gray), loxP-flanked (black), or no product per
total amplifications. See Figure S1 for PCR strategy
and examples of PCR results and Table S1 for the
entire data set.
(B) In-vitro-expanded peritoneal MCs were stimulated
with anti-DNP IgE plus DNP; bone-marrow-derived
DCs were stimulated with LPS. TNF levels in super-
natants were quantified by ELISA; n = 5 mice/group;
two culture samples/mouse.
(C) MC numbers in the peritoneum and in ear skin
were quantified by flow cytometry; n = 10 mice/group.
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Figure 2. TNF Inactivation in MCs Did Not Affect MC Degranulation In Vivo and In Vitro
(A) Mcpt5-Cre+TNFFL/FL and Cre control mice were sensitized with DNFB or vehicle control. Four hours later, ear skin sections were stained with Giemsa and
MCs were categorized as resting (non-degranulated), moderately degranulated, or extensively degranulated according to the histology examples; scale bar,
5 mm.
(B) The total number of mast cells was counted up to 5 mm length of tissue section per animal and set to 100%, and relative frequencies of extensively de-
granulated (black bars), moderately degranulated (gray bars), and resting (white bar) mast cells were determined. n = 5 per group; mean ± SD.
(C–E) Peritoneal MCs (PMCs) were isolated from Mcpt5-Cre+TNFFL/FL and Cre controls and expanded in vitro for 8 days. PMCs were stimulated with the
ionophore A23187 for 24 hr or PBS as control. (C) Beta-hexosaminidase levels in PMC supernatants were quantified by spectrophotometric analysis of p-ni-
trophenyl-N-acetyl b-D glucosaminehydrolysis. (D) Leukotriene levels weremeasured using leukotriene C4 enzyme immuno assay (GE Healthcare). (E) Histamine
levels were quantified using Histamine Elisa (eBioscience). n = 5 mice/group and two cultures per mouse. Data are presented as mean ± SD.from sensitized skin to skin-draining LNs. Total CD11c+MHCIIhi
DC and FITC-bearing DC numbers were surprisingly not sig-
nificantly reduced in Mcpt5-Cre+TNFFL/FL mice compared to
Cre littermates (Figure 5A). However, when discriminating DC
subsets in respect of CD8 surface expression, we found the frac-
tion of FITC+CD8+ LN DCs to be significantly reduced in mice
lacking MC-TNF. In turn, the fraction of FITC+CD8 DCs was
shifted to an increased proportion in Mcpt5-Cre+TNFFL/FL
mice. To ensure MC-TNF effects on-DC migration instead off-402 Cell Reports 13, 399–411, October 13, 2015 ª2015 The AuthorsDC homeostasis or turnover, we quantified dermal DC subsets
in steady state. All langerin-negative dermal DC subsets
remained unimpaired by the absence of MC-derived TNF in
steady state, whereas epidermal Langerhans cell numbers
were decreased and langerin+CD11b+ DCs were slightly in-
creased in Mcpt5-Cre+TNFFL/FL (Figure S2). Accordingly, CD8+
DC numbers in LNs in steady-state conditions were not signifi-
cantly altered Mcpt5-Cre+TNFFL/FL lacking MC-derived TNF as
compared to Cre littermate controls (data not shown).
Figure 3. The Adaptive Immune Response to Contact Allergens Is Impaired in Absence of Mast-Cell-Derived TNF
(A) The ear-swelling response of sensitized Mcpt5-Cre+TNFFL/FL and Cre mice was measured 24 hr post-DNFB challenge or vehicle treatment. n = 10; two
independent experiments (WT controls n = 5); mean ± SD; ***p < 0.005.
(B) Infiltrating leukocytes were quantified in challenged ear skin 24 hr post-DNFB challenge in Mcpt5-Cre+TNFFL/FL versus Cre mice (n = 8; two independent
experiments) and vehicle-treated WT mice (n = 3). Neutrophils were defined as Ly6G+CD11b+F4/80 cells. **p < 0.01; ***p < 0.005.
(C) Pooled LN T cells isolated fromDNFB-sensitizedWTmicewere adoptively transferred intoMcpt5-Cre+TNFFL/FL orCremice. Recipient micewere challenged
with DNFB 24 hr after adoptive transfer, and ear swelling was measured 24 hr post-challenge (n = 8/group; two independent experiments). As control, untreated
WTmice andWTmice transferred with T cells from vehicle-treated donors were challenged with DNFB and untreatedWTwere challenged with vehicle alone (n =
4/group). Mean ± SD; ***p < 0.005.
(D) Numbers of LN cell subsets were quantified in Mcpt5-Cre+TNFFL/FL and Cre mice 3 days after DNFB sensitization using flow cytometry in comparison to
vehicle-treated mice. n = 8/group; two independent experiments; ***p < 0.005.We next evaluated the impact of MC-TNF on DC maturation
and antigen-presenting capacity. MHCII, CD80, and CD86
surface expression was significantly reduced on FITC+CD8+
LN DCs in Mcpt5-Cre+TNFFL/FL mice compared to Cre con-
trols (Figure 5B), whereas CD40 was not affected. In contrast,
FITC+CD8 DCs showed an induced surface expression of
MHCII, CD86, and CD80, albeit to a lesser extent as CD8+
DCs, but no impact of MC-TNF. Because T cell expansion
and antigen-specific skin inflammation was studied using
the hapten DNFB, we aimed to exclude hapten-restricted fea-
tures of MC-TNF on DC maturation. Consistent with theCassessment of T cell expansion, we analyzed DC numbers
and costimulatory molecule expression on inguinal LN DCs
in Mcpt5-Cre+TNFFL/FL and Cre mice 72 hr post-DNFB.
Despite the inability to focus on DCs recently immigrated
from sensitized skin, we observed a profound reduction of
CD8+ DC numbers in Mcpt5-Cre+TNFFL/FL mice (Figure S3).
Moreover, CD8+ DCs showed reduced surface levels of
MHCII, CD80, and CD86. In contrast, CD8 DC numbers
were slightly reduced in the absence of MC-TNF without al-
terations in MHCII and costimulatory molecule expression
levels. Collectively, our data indicate that the presence ofell Reports 13, 399–411, October 13, 2015 ª2015 The Authors 403
Figure 4. T Cells Primed in Absence of MC-Derived TNF Exhibit a Reduced Capacity to Elicit Efficient CHS Response
Equal LN T cell numbers of sensitized Mcpt5-Cre+TNFFL/FL or Cre mice were adoptively transferred into naive WT recipients (n = 12/group; two independent
experiments). WT recipients were challenged with DNFB (D) on the ear 24 hr post-transfer. As control, non-sensitized WT mice (n = 3) and WT recipients
adoptively transferred by LN T cells from vehicle-treated Cremice (n = 3) were challenged with DNFB, and non-sensitized WTmice were treated with vehicle (v)
alone (n = 3). Twenty-four hours post-challenge, (A) adaptive ear-swelling response was measured (mean ± SD) and (B) cell subsets in challenged ear skin were
quantified by flow cytometry. Cell subsets were defined by expression of the following surfacemarkers: neutrophils (Ly6G+CD11b+F4/80); restingmacrophages
(CD11b+F4/80+Ly6G); and inflammatory macrophages (Ly6G+Ly6C+CD11b+F4/80+). ***p < 0.005.
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Figure 5. Reduced Migration and Maturation of CD8+ DCs in Absence of MC-Derived TNF
Mcpt5-Cre+TNFFL/FL (n = 10) and Cremice (n = 8) were sensitized with FITC on the shaved back; control mice were treated with vehicle alone. Forty-eight hours
post-sensitization, inguinal LNs were isolated.
(A) Numbers of CD11c+MHCIIhiDCs and FITC-bearing DC subsets were quantified using flow cytometry. *p < 0.05; ***p < 0.005.
(B) Indicated protein surface expression was assessed on FITC-bearing CD11c+MHCIIhi DCs as mean fluorescence intensity (MFI); two independent experi-
ments; *p < 0.05; **p < 0.01; ***p < 0.005. Examples of the certain protein surface expression by CD8+ DCs fromMcpt5-Cre+TNFFL/FL and Cremice are further
presented as FACS histogram overlays.MC-TNF during skin DC activation promotes their maturation
and migration to draining LNs.
MC-TNF Amplifies the CD8+ T-Cell-Priming Efficiency
of DCs
Next, we askedwhetherMC-TNF effects onCD8+DCmaturation
and LN immigration are accompanied by modulation of their T-
cell-priming capacity. We therefore isolated inguinal LN DCsCfrom Mcpt5-Cre+TNFFL/FL and Cre mice 6 days post-DNFB
sensitization and incubated equal DC numbers ex vivo with
CFSE-stained inguinal LN CD4+ or CD8+ T cells from sensitized
WT mice. T cell proliferation as a consequence of hapten-spe-
cific restimulation was assessed 6 days later by means of
CFSE dilution. T cell coculture with Mcpt5-Cre+TNFFL/FL DCs
yielded a reduced frequency of CFSElow-proliferated CD8+
T cells accompanied by a reduced cell division rate as indicatedell Reports 13, 399–411, October 13, 2015 ª2015 The Authors 405
Figure 6. CD8+ DCs Activated in Mice Lacking MC-Derived TNF Are Less Efficient in CD8+ T Cell Priming In Vitro and In Vivo
(A) DCs isolated from inguinal LNs of DNFB-sensitized Mcpt5-Cre+TNFFL/FL mice or Cre controls were incubated ex vivo with CFSE-stained CD4+ or CD8+
T cells from DNFB-sensitized WT mice for 6 days. T cell proliferation was analyzed by means of CFSE dilution as MFI and as fraction of proliferated T cells from
total T cell number (n = 6 mice/group; two independent experiments; triplicates).
(B) Inguinal LN T cells were isolated from sensitized WT mice at day 6 after sensitization, CFSE stained, and adoptively transferred into non-sensitized Mcpt5-
Cre+TNFFL/FL or Cre recipient mice. Recipients were sensitized by DNFB on back skin immediately after LN cell transfer. Four days later, inguinal LNs of
recipients were isolated and in vivo CD4+/CD8+ T cell proliferation was analyzed as CFSE dilution by flow cytometry (n = 5/group; one of two independent
experiments).
(legend continued on next page)
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by the increased fluorescence intensity (Figure 6A), compared
to cocultures with Cre DCs. In contrast, only a slight reduction
of CD4+ T cell proliferation could be detected. In addition
to ex vivo analysis of DC restimulation capacity, we evaluated
the hapten-specific T cell restimulation in vivo (Figure 6B). To
this end, CFSE-stained inguinal LN T cells isolated from sensi-
tized WT donor mice 6 days post-sensitization were adoptively
transferred into non-sensitized Mcpt5-Cre+TNFFL/FL or Cre
mice. Recipient mice were sensitized by DNFB immediately after
T cell transfer, and donor T cell proliferation in inguinal LNs was
assessed as CFSE dilution 4 days post-sensitization. Prolifera-
tion of both CD4+ and CD8+ donor T cells was efficiently induced
upon sensitization inCremice. Importantly, the hapten-specific
proliferation of CD8+ donor T cells was dramatically diminished
in the absence of MC-TNF in Mcpt5-Cre+TNFFL/FL mice to
almost the level of vehicle-treated controls (Figure 6B). Addition-
ally, the absence of MC-TNF slightly reduced the efficiency of
CD4+ T cell proliferation compared to Cre controls albeit to
a lesser extent as detected for CD8+ T cell proliferation. In
both approaches of hapten-specific restimulation, the low fre-
quency of hapten-specific T cells limited the number of detect-
able proliferated T cells. We further confirmed the impact of
MC-TNF on CD8+ T cell priming without this limitation using
the strategy of DEC205 targeting. Dudziak et al. (2007) identified
CD8+CD205+ DCs to most efficiently prime OVA-specific trans-
genic CD8+ T cells (OT-I) by targeting this DC subset with OVA-
coupled antibodies directed against DEC205 in vivo. Ova-
coupled aDEC205 or Ova-coupled isotype control antibodies
were injected i.d. into the back skin of Mcpt5-Cre+TNFFL/FL or
Cremice. Twenty-four hours later, purified CFSE-stained trans-
genic CD8+ OTI T cells were adoptively transferred into anti-
body-treated recipients, which were subsequently sensitized
with DNFB. Proliferation of OTI T cells isolated from inguinal
LNs of Mcpt5-Cre+TNFFL/FL or Cre recipient mice was deter-
mined as CFSE dilution 3 days post-sensitization. We detected
a high number of proliferated OTI T cells in inguinal LNs of
Ova-aDEC205-treated mice that executed several cell cycles,
indicating efficient migration of Ova-bearing DCs from skin to
inguinal LNs and T cell priming. In Ova isotype control-treated
mice, almost no proliferation was evident. Importantly, when
compared to Cre control mice, Mcpt5-Cre+TNFFL/FL mice ex-
hibited a less-efficient priming of OTI T cells as reflected by a
lower frequency of proliferated OTI cells and an increased
mean CFSE fluorescence intensity, indicating reduced numbers
of cell cycles (Figure 6C). Collectively, our data prove that MC-
TNF is of critical importance for CD8+ DC maturation, migration
to skin-draining LNs, and CD8+ T-cell-priming capacity.
DISCUSSION
Due to the lack of better models, most knowledge about the
in vivo relevance of MCs in adaptive immune responses is based
on mice carrying mutations of the MC growth factor SCF or its(C) Ova-DEC205-mAb or Ova-isotype control was injected i.d. into back skin of
purified CFSE-stained transgenic OTI CD8+ T cells were adoptively transferred int
sensitized on back skin. Three days after transfer and sensitization, recipient
determined as CFSE dilution. *p < 0.05; **p < 0.01; ***p < 0.005.
Creceptor Kit to obtain various degrees of MC deficiency. SCF
or Kit mutant mice have been widely used to investigate MC
functions in vivo over the past 30 years (Galli et al., 2008). How-
ever, the interpretation of results obtained with thesemodels has
to take into account that the mutant mice feature complex alter-
ations of their immune system, which go beyond the lack of MCs
(Nigrovic et al., 2008). Specific functions of certainMCmediators
in vivo have been generally defined by transfer of in-vitro-
expanded, bone-marrow-derived MCs (BMMCs) from WT and
the mediator mutant strains to MC-deficient Kit mutant mice.
However, these ‘‘MC knockin’’ approaches still involve some
disadvantages, including (1) the persistence of thementioned al-
terations of myeloid cell subsets in Kit mutant mice, which may
bias MC effects or MC responses; (2) abnormal MC numbers
or tissue distributions in BMMC-engrafted recipients (Du et al.,
1996; Cozzi et al., 2011); and (3) an inadequate reflection of
mature connective-tissue-type MC (CTMC) features by the en-
grafted immature BMMCs (Mrabet-Dahbi et al., 2009).
We have recently generated a MC-specific Cre line that allows
for the inducible or constitutive depletion of MCs but also for the
inactivation of certain target genes selectively in MCs (Dudeck
et al., 2011a; Peschke et al., 2014, 2015). Using our model
of MC-deficiency, we identified MCs as a prerequisite for effi-
cient DC migration to skin-draining LNs and adaptive immunity
response upon CHS responses (Dudeck et al., 2011a), but
the underlying molecular mechanism remains poorly defined.
Whereas DC activation during contact sensitization has been
shown to depend on TLR2/4 sensing of endogenous ligands
and purinergic receptor signaling (Martin et al., 2008; Esser
et al., 2012; Weber et al., 2010), the mechanism of MC activation
has so far not been identified. Based on our previous observation
that MCs respond to hapten exposure by rapid degranulation
(Dudeck et al., 2011a), we here specify the relevance of TNF in
the observed MC effects on CHS responses. MCs exhibit the
unique feature to store preformed TNF in secretory granules
that are released within seconds after danger signaling. We
clearly prove Mcpt5-Cre+TNFFL/FL mice to exhibit efficient TNF
deletion in CTMCs, therefore allowing us to study the impact of
MC-derived TNF without alterations in MC numbers and pleio-
tropic Kit effects. Moreover, we defined that the MCs’ degranu-
lation and secretory response is not affected by the absence of
the granule-mediator TNF. The absence of MC-derived TNF
does not evoke alterations in skin-resident immune cell numbers
under healthy conditions except for a slight shift of the epidermal
to dermal langerin-expressing DC ratio. However, this slight ef-
fect can be neglected in the CHS model of adaptive responses
because it has been reported that Langerhans cells and lan-
gerin-positive dermal DCs do not contribute to sensitization
but rather play a regulatory role in CHS (Honda et al., 2010).
Focusing on the adaptive immune responses initiated during
the sensitization process, we here demonstrate that MC-derived
TNF distinctly amplifies LN hypertrophy and T cell expansion and
functionality. Concerning this matter, our data are in agreementMcpt5-Cre+TNFFL/FL (n = 7) or Cre controls (n = 6). Twenty-four hours later,
o ab-treatedMcpt5-Cre+TNFFL/FL or Cremice and recipient mice were DNFB
inguinal LNs were isolated and in vivo proliferation of OTI CD8+ T cells was
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with reports by Abraham and colleagues demonstrating MC
functions in bacterial infection and postulating MC effects over
distance (McLachlan et al., 2003; Shelburne et al., 2009; Kunder
et al., 2009). Importantly, we additively prove the TNF released or
exposed by skin-resident MCs to critically support the migration
of dermal DC subsets to the draining LNs that finally represent
immigrated LN CD8+ DCs. Although we previously found that
the complete absence of MCs impairs on total DC migration
upon hapten sensitization, we can here add further insight into
the underlying mechanism that TNF specifically targets CD8+
DCs. The specific analysis of the recently identified subsets of
CD8+ and CD8 DCs may be the reason for the contradiction
to the report of Suto et al. (2006), who described MC-associated
TNF to contribute only to the initial stage of FITC-induced dermal
DCmigration using the above-describedmodel ofMC knockin of
in-vitro-expanded WT and TNF/ BMMCs into MC-deficient
KitW-sh/W-sh mice. In contrast, our findings are in line with the
report of de Vries et al. (2011), describing MCs to mediate the
accumulation of graft-derived DCs in draining LNs in a TNF-
dependent manner.
MC-derived TNF further amplifies CD8+ DC maturation and
CD8+ T cell priming capacity. The distinct impact of MC-derived
TNF on DC functionality is all the more astonishing as soluble
TNF is abundantly released by skin-resident macrophages and
by DCs themselves to the time point of DC activation and migra-
tion, e.g., between 18 hr and 48 hr. In a previous report, we
demonstrated a dynamic interaction of mature CTMCs and
bone-marrow-derived DCs (BMDCs) in vitro, inducing DC matu-
ration (Dudeck et al., 2011b). Confirming our finding, Otsuka
et al. (2011) reported on a TNF-dependent in vitro communica-
tion of BMMCs and BMDCs enhancing BMDC maturation but
also upregulating membrane-bound TNF on BMMCs. A dynamic
interaction of skin-resident MCs and DCs in vivo still needs to be
proven but may allow for DC sensing of membrane-bound TNF
exposed by MCs. Moreover, the distinct effect of MC-TNF may
result from its embedding and stabilization within the heparin
core of releasedMCgranules. Recently, Joulia et al. (2015) prove
MCs to form degranulatory synapses with target cells inducing a
polarized exocytosis of their granules. Given the hapten-induced
MC degranulation, this way of communication may explain the
distinct effect of MC-derived TNF despite the simultaneous
release of soluble TNF by other skin-resident cells.
CD8+ DCs have been demonstrated to be the most-efficiently
cross-presenting DC subset in mice, thereby inducing potent
CD8+ T cell responses (Dudziak et al., 2007; Burgdorf et al.,
2007; Hildner et al., 2008). The impact of MC-TNF on CD8+
DCs and their T cell sensitizing capacity thereby explains
MC-TNF effects on the hapten-specific and predominantly
CD8+ T-cell-driven adaptive inflammation post-challenge (Ka-
plan et al., 2012; Gocinski and Tigelaar, 1990; Gorbachev
et al., 2001). However, a possible direct impact of MC-TNF on
T cell priming within the LN over distance or upon migration of
MCs to draining LNs can presently not be excluded. The down-
regulation of integrin surface expression and internalization
of antigen-uptake-related C-type lectin receptors impedes
clear-cut definition of LN DC subsets recently immigrated from
inflamed peripheral tissues. However, a recent report exposed
peripheral CD103+ DCs as developmentally related to CD8+ con-408 Cell Reports 13, 399–411, October 13, 2015 ª2015 The Authorsventional DCs in lymphoid tissues, thereby probably reflecting a
subset of LN CD8+ DCs migrated from periphery to draining LNs
(Edelson et al., 2010). Moreover, CD103+ dermal DCs have been
shown to be the main migratory subtype that efficiently cross-
presents skin-derived self-antigens to naive CD8+ T cells (Bed-
oui et al., 2009).
Collectively, TNF peripherally provided by skin-resident MCs
induces the required pro-inflammatory microenvironment for
efficient on-site DC activation, their migration to skin-draining
LNs, and priming of respective antigen-specific T cells, thus link-
ing MC-TNF effects on CD8+ T cell priming to DC modulation.
EXPERIMENTAL PROCEDURES
Mice
Mcpt5-Cre TNFFL/FL mice (on C57BL/6 background) were housed at the
Experimental Centre at the TU Dresden, under specific pathogen-free condi-
tions. CD45.2+ OT-I mice were obtained from The Jackson Laboratory and
backcrossed with CD45.1+ B6.SJL-PtprcaPep3b/BoyJ mice. In all experi-
ments, mice were used at the age of 8–16 weeks. Littermates were used as
controls. All procedures were in accordancewith institutional guidelines on an-
imal welfare and were approved by the Landesdirektion Dresden (24-9168.11-
1/2012-38).
CHS
Mice were sensitized with 100 ml 0.5% DNFB (w/v) in acetone/olive oil (4:1) on
the shaved back and challenged 6 days later with 20 ml 0.2%DNFB (10 ml each
side of the ear). Vehicle controls were sensitized but challenged with the
respective solvent only. Ear thickness was measured before and 24 hr after
challenge with an engineer’s micrometer (Mitutoyo). Ear swelling was deter-
mined as the percent increase compared to prechallenge ear thickness.
Preparation of Cell Suspensions and FACS Analysis
For preparation of skin cell suspensions, samples of ear or abdominal skin
were cut into small pieces and digested in 1 ml DMEM containing 20 mM
HEPES, 0.025mg/ml Liberase TM, 396 U/ml DNase I, and 0.5mg/ml hyaluron-
idase at 37C, 1,400 rpm for 1 hr. Samples were passed through a 40-mm
sieve, and the cell suspension was washed twice with PBS. For flow cytometry
analysis, cells isolated from skin, skin-draining LNs, or peritoneal lavage were
resuspended in PBS/2% BSA. 2–5 3 105 cells were stained with monoclonal
antibodies in 100 ml staining solution 30 min at 4C. Cell suspensions were
washed twice and were resuspended in 200 ml PBS/2% BSA. Analysis was
done using theMiltenyi MacsQuant flow cytometer with MacsQuant or FlowJo
Analysis Software.
Quantification of MC Degranulation on DNFB-Treated Ear Skin
Sections
Mouse ears were sensitized with 0.5% DNFB (20 ml) or vehicle control on the
ear pinnae, and tissue were excised after 4 hr. Formalin-fixed paraffin tissue
sections were stained for MCs with Giemsa staining. MCs degranulation
was assessed up to 5 mm length of tissue section per animal at final magnifi-
cation of 2003. MCs appearing as diffuse accumulations of metachromatic
granules with/without distinguishable cell boundaries are graded as ‘‘exten-
sively degranulated’’ cells. MCs with clearly distinguishable cell boundary
but surrounded by numerous granules were classified as ‘‘moderately degra-
nulated’’. Resting cells were defined as the MCs with no sign of degranulation,
and corresponding relative frequencies were plotted (Dudeck et al., 2011a).
PCMCs
PCMCs were obtained as described previously (Dudeck et al., 2011b; Mrabet-
Dahbi et al., 2009). Briefly, peritoneal lavage was isolated from Mcpt5-
Cre+TNFFL/FL mice and Cre littermate controls, and cells were cultured in
RPMI, supplemented to final concentration of 10%FCS, 1%penicillin/strepto-
mycin, 10 ng/ml recombinantmurine IL-3 (BioSource/Invitrogen), and 30 ng/ml
recombinant rat SCF (BioSource). After 48 hr, non-adherent cells were carefully
removed and replaced by fresh culture medium to enhance the purity of result-
ing MCs. PCMCs were used after 8 days of culture; purity of PCMCs was as-
sessed by expression of c-kit (CD117) and FcεRI using flow cytometry. PCMCs
were used at a purity of >95%; if necessary, PCMCs were enriched using the
mouse CD117 positive selection kit (Miltenyi).
PCMC Stimulation and Quantification of Beta-hexosaminidase,
Histamine, and Leukotriene C4
PCMCs were washed twice with PBS to withdrawal IL-3 and SCF, afterward
stimulated with the A23187 ionophore (50 mg/ml) for 24 hr, and supernatants
as well as whole-cell lysates were harvested. Beta-hexosaminidase as a
marker of MC degranulation was measured by spectrophotometric analysis
of p-nitrophenyl-N-acetyl b-D glucosaminehydrolysis hydrolysis (Sigma-Al-
drich). Beta-hexosaminidase release was determined as percent release of
total content (percent release = 100 3 amount supernatant/[amount in super-
natant + cell lysate]). Histamine was measured in supernatants using the
Enzyme Immunoassay for Histamine kit (DRG, histamine cell culture Elisa,
DRG International) according to the manufacturer’s instructions. Leukotriene
C4 levels were measured using Amersham Leukotriene C4 Bio trak system
(GE Healthcare). Leukotriene C4 standard and sample concentrations were
derived using polynomial plot with R2 = 0.9851 value.
Analysis of LN Hypertrophy, DC Migration, and Maturation
Mice were sensitized with 0.5%DNFB on the shaved back. Seventy-two hours
later, both inguinal LNs were isolated and CD45+ cells, CD4+FoxP3 T cells,
and CD8+ T cells and CD19+ B cells were quantified by flow cytometry. For
evaluation of DC migration from skin to draining LNs, mice were sensitized
with FITC (1% w/v in dibutylphthalate/acetone 1/1) or vehicle only on the
shaved back. Forty-eight hours later, both inguinal LNs were isolated and
numbers of CD45+ cells, CD11c+MHCIIhi DCs, FITC+CD11c+ MHCIIhi DCs,
and CD8+/CD8 DC fractions were analyzed by flow cytometry.
Trans-sensitization Adoptive Transfer Experiments
For trans-sensitization experiments, donor mice were sensitized with 100 ml
0.5% DNFB on the shaved back. Six days later, T cells from inguinal LNs were
enriched negatively using a Pan T cell isolation kit (Miltenyi), and 2 3 106 cells
in 100 ml saline were adoptively transferred to non-sensitized recipient mice
by retro-orbital injection. Twenty-four hours after transfer, recipient mice were
challenged by 20 ml 0.2%DNFB on the ear skin, and skin inflammation was as-
sessed 24 hr after challenge as ear swelling responses and immune cell infiltra-
tion into challenged skin. Vehicle-treated mice, DNFB-challenged recipient
mice transferred with T cells from vehicle-treated donor mice, and DNFB-chal-
lenged mice without any transfer of donor cells served as negative controls.
Hapten-Specific T Cell Restimulation In Vitro and In Vivo
For in vitro hapten-specific restimulation of T cells, Mcpt5-Cre+TNFFL/FL mice
and Cre controls were sensitized with DNFB on the back as described and
both inguinal LNs were isolated 3 days later. CD11c+DCs were separated
using mouse CD11c microbeads (Miltenyi), resuspended in complete RPMI,
supplemented with 10% FCS and 1% penicillin/streptomycin, and 2 3 105
DCs/200 ml were seeded per well in 96-well plates. CD4+ and CD8+ T cells
were isolated from inguinal LNs of DNFB-sensitized C57BL/6WT at day 6 after
sensitization, enriched by positive selection using paramagnetic CD8+ or CD4+
beads (Miltenyi), and labeled with CFSE. 4 3 105 CD4+ or CD8+ T cells were
added to pre-seeded DCs and co-incubated for 6 days. T cell proliferation
was analyzed by means of CFSE dilution as MFI and as fraction of proliferated
T cells from total T cell number. For in vivo hapten-specific T cell restimulation,
inguinal LN T cells were isolated from sensitized WT mice at day 6 after sensi-
tization, CFSE stained, and adoptively transferred into non-sensitized Mcpt5-
Cre+TNFFL/FL or Cre recipient mice. Recipient mice were sensitized by DNFB
on back skin immediately after LN cell transfer. Four days later, inguinal LNs of
recipients were isolated and T cell proliferation was analyzed as proliferation
dye dilution by flow cytometry.
CHS-Conditioned OTI In Vivo Priming
For T cell transfer, single-cell suspensions from murine spleens and LNs of
CD45.1+ OT-I mice were prepared as previously described (Dudziak et al.,C2007) and kept on ice in PBS/2% FCS. Cells were filtered washed with
MACS buffer (PBS and 0.5% BSA). T cells were enriched by positive selection
using paramagnetic CD8+ beads (Miltenyi) and labeled with CFSE. Each 1 mg
of the targeting antibodies aDEC205-Ova or Iso-Ova were i.d. injected
into back skin of Mcpt5-Cre+TNFFL/FL or Cre controls. Twenty-four hours
later, 13 106 CFSE-stained transgenic OTI CD8+ T cells were adoptively trans-
ferred into ab-treated congenic CD45.2+ Mcpt5-Cre+TNFFL/FL mice or Cre
controls and recipient mice were DNFB sensitized on back skin. Three days
after transfer and sensitization, inguinal LNs of recipient mice were isolated
and proliferation of OTI CD8+ T cells was determined as CFSE dilution using
flow cytometry.
Statistical Analysis
Data are shown asmeans ±SD or as box plot with line at median and square at
mean, percentile 25/75, whisker 5–95. Statistical analysis was performed with
the Student’s t test. Significance levels are indicated in each figure.SUPPLEMENTAL INFORMATION
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